Smallcap healthcare company Park Medi World witnessed sustained buying interest in Monday’s trading session after brokerage firm Khandwala Securities projected strong long-term growth potential for the hospital operator amid rising healthcare demand in North India.

The stock rose 4.28 percent during intraday trade on the NSE to ₹260.43 apiece around 11:30 a.m., marking its fourth consecutive session of gains. The rally followed a positive brokerage assessment that highlighted the company’s expanding hospital network, improving industry dynamics, and scalable business model.

According to the brokerage note, Park Medi World currently operates 16 hospitals with a combined bed capacity of 3,960 beds across North India. The company has been steadily increasing its footprint in the region while positioning itself as a provider of advanced multispecialty healthcare services at relatively affordable pricing levels.

The positive outlook comes at a time when India’s healthcare infrastructure remains under pressure from rising patient demand, particularly in tier-2 and tier-3 cities. North India continues to face relatively low hospital bed density compared to global benchmarks, creating a long runway for organised hospital chains that are expanding beyond metropolitan markets.

Khandwala Securities noted that Park Medi World plans to expand its capacity to over 5,000 beds by FY28, signalling a sizeable growth pipeline over the next few years. The brokerage said the company’s execution capabilities and balance sheet strength could support this expansion without creating significant financial stress.

The healthcare sector in India has increasingly attracted investor attention following sustained growth in insurance penetration, rising health awareness, higher chronic disease incidence, and increased preference for organised healthcare providers. Hospital operators with scalable regional networks are being viewed favourably as the sector gradually shifts from fragmented local facilities toward larger institutional chains.

For Park Medi World, the expansion strategy appears closely tied to the growing demand for affordable yet specialised healthcare services outside major urban centres. Industry analysts have repeatedly highlighted that underserved regions continue to offer stronger patient volume growth compared to saturated metropolitan clusters.

Khandwala Securities also pointed to the company’s near debt-free balance sheet as a key strength. In an industry where hospital expansion typically requires significant capital expenditure and long gestation periods, lower leverage provides operational flexibility and reduces earnings volatility during expansion cycles.

The brokerage maintained its “Overweight” rating on the stock and recommended it as a long-term investment opportunity. It added that formalisation within India’s healthcare ecosystem could further benefit organised hospital operators with established infrastructure and execution track records.

The market reaction reflects broader investor optimism toward healthcare infrastructure plays, particularly companies that are positioned to benefit from India’s widening healthcare access gap. Rising disposable incomes, increasing government focus on healthcare accessibility, and growth in private insurance coverage continue to support long-term demand visibility for the sector.

However, despite the positive outlook, investors may continue to monitor several execution-related risks. Hospital expansion projects are capital intensive and often involve regulatory approvals, staffing challenges, occupancy ramp-up periods, and operational integration risks. Margin sustainability also remains dependent on maintaining patient volumes and controlling operating costs amid inflationary pressures.